Matches in Wikidata for { <http://www.wikidata.org/entity/Q59563699> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q59563699 description "2007 թվականի հոկտեմբերի 11-ին հրատարակված գիտական հոդված" @default.
- Q59563699 description "article scientifique publié en 2007" @default.
- Q59563699 description "artículu científicu espublizáu n'ochobre de 2007" @default.
- Q59563699 description "im Oktober 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59563699 description "scientific article published on 11 October 2007" @default.
- Q59563699 description "wetenschappelijk artikel" @default.
- Q59563699 description "наукова стаття, опублікована в жовтні 2007" @default.
- Q59563699 name "Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis" @default.
- Q59563699 name "Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis" @default.
- Q59563699 type Item @default.
- Q59563699 label "Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis" @default.
- Q59563699 label "Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis" @default.
- Q59563699 prefLabel "Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis" @default.
- Q59563699 prefLabel "Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn’s disease: a cost-effectiveness analysis" @default.
- Q59563699 P1433 Q59563699-07B6AE88-3BC3-4EDD-94D2-93F49B0EF3B7 @default.
- Q59563699 P1476 Q59563699-A6DE39D6-41DF-4EE5-A71D-5C50CC828CEF @default.
- Q59563699 P2093 Q59563699-0B23C322-1557-4293-93B7-6483A9262642 @default.
- Q59563699 P2093 Q59563699-E42AD80B-9DFE-4002-9FDD-BFCC2C78B2BA @default.
- Q59563699 P304 Q59563699-A968AABD-8B0E-4CEA-A612-61B8112F4BA1 @default.
- Q59563699 P31 Q59563699-783CB24E-04F3-433E-9B82-B69197D5F4E5 @default.
- Q59563699 P356 Q59563699-2DB9F58B-0046-477D-AA02-77D3945D88EA @default.
- Q59563699 P407 Q59563699-216E135F-E294-48DA-825F-1F7E6083768F @default.
- Q59563699 P433 Q59563699-9AB9BFC0-F706-4F02-A875-6D551E3EDB44 @default.
- Q59563699 P478 Q59563699-032DFCE6-EFAA-45A7-B619-2D218A1B7710 @default.
- Q59563699 P50 Q59563699-C2C5BECC-DC77-499B-B697-AD84C2AE94FA @default.
- Q59563699 P50 Q59563699-DB60E28C-A246-43D1-A613-1E9AA2C709AE @default.
- Q59563699 P577 Q59563699-BF0FC054-969E-489E-89AE-2026709C213C @default.
- Q59563699 P698 Q59563699-6F14EC59-B446-4DFA-9BA3-80489314B987 @default.
- Q59563699 P921 Q59563699-DE741A89-FF56-4217-B652-A9DCC8BD65FD @default.
- Q59563699 P356 J.1365-2036.2007.03548.X @default.
- Q59563699 P698 17931345 @default.
- Q59563699 P1433 Q4726656 @default.
- Q59563699 P1476 "Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis" @default.
- Q59563699 P2093 "B E Sands" @default.
- Q59563699 P2093 "J Korzenik" @default.
- Q59563699 P304 "1509-1520" @default.
- Q59563699 P31 Q13442814 @default.
- Q59563699 P356 "10.1111/J.1365-2036.2007.03548.X" @default.
- Q59563699 P407 Q1860 @default.
- Q59563699 P433 "11-12" @default.
- Q59563699 P478 "26" @default.
- Q59563699 P50 Q38544138 @default.
- Q59563699 P50 Q56760983 @default.
- Q59563699 P577 "2007-10-11T00:00:00Z" @default.
- Q59563699 P698 "17931345" @default.
- Q59563699 P921 Q348260 @default.